{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:41:44Z","timestamp":1791931304165,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dental Clinics of North America"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.cden.2004.07.004","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:11Z","timestamp":1113835991000},"page":"91-106","source":"Crossref","is-referenced-by-count":24,"title":["Mucous membrane pemphigoid"],"prefix":"10.1016","volume":"49","author":[{"given":"Thomas P.","family":"Sollecito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesta","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cden.2004.07.004_bib1","series-title":"Burket's oral medicine: diagnosis and treatment","first-page":"73","article-title":"Ulcerative, vesicular, and bullous lesions","author":"Greenberg","year":"2003"},{"key":"10.1016\/j.cden.2004.07.004_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1079-2104(99)70110-1","article-title":"A retrospective study of the management of oral mucous membrane pemphigoid with dapsone","volume":"88","author":"Ciarrocca","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.cden.2004.07.004_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archderm.1993.01680250060007","volume":"129","author":"Chan","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1079-2104(99)70194-0","article-title":"Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity","volume":"88","author":"Scully","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Endod"},{"key":"10.1016\/j.cden.2004.07.004_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of sub-epidermal autoimmune bullous skin diseases in 3 French regions","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0161-6420(81)35069-6","article-title":"Ocular cicatricial pemphigoid","volume":"88","author":"Mondino","year":"1981","journal-title":"Opthalmology"},{"key":"10.1016\/j.cden.2004.07.004_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0030-4220(81)90124-9","article-title":"Direct immunofluorescence in oral mucosal disease: a diagnostic analysis of 130 cases","volume":"51","author":"Daniels","year":"1981","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.cden.2004.07.004_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0190-9622(91)70159-Y","article-title":"Cicatricial pemphigoid","volume":"24","author":"Ahmed","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0738-081X(93)90160-E","article-title":"Drug-induced cicatricial pemphigoid and acquired epidermolysis bullosa","volume":"11","author":"Van Joost","year":"1993","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0738-081X(93)90164-8","article-title":"Drug-induced blistering oral lesions","volume":"11","author":"Laskaris","year":"1993","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib11","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/0190-9622(91)70299-H","article-title":"Association of autoimmunity and cicatricial pemphigoid: is there an immunogenetic basis?","volume":"25","author":"Nayar","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib12","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allel HLA-DQB1\u22170301 is present in clinical variant of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cden.2004.07.004_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2133.1988.tb01744.x","article-title":"Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study","volume":"118","author":"Venning","year":"1988","journal-title":"Br J Dermaol"},{"key":"10.1016\/j.cden.2004.07.004_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0030-4220(94)90312-3","article-title":"Immunopathology of oral mucosal ulcerative, desquamative and bullous diseases","volume":"77","author":"Eversole","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.cden.2004.07.004_bib16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1601-0825.1996.tb00221.x","article-title":"Adhesion molecules and oral mucosal diseases","volume":"2","author":"Eversole","year":"1996","journal-title":"Oral Dis"},{"key":"10.1016\/j.cden.2004.07.004_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S1079-2104(99)70056-9","article-title":"Contemporary issues in the diagnosis of oral pemphigoid: a selective review of the literature","volume":"88","author":"Dayan","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.cden.2004.07.004_bib18","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/1523-1747.ep12606244","article-title":"Adhesion molecules, II: interactions of keratinocytes with epidermal basement membrane","volume":"104","author":"Yancey","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1083\/jcb.120.2.523","article-title":"Interaction of integrins alpha 3 beta 1 and alpha 2 beta 1: potential role in keratinocyte intercellular adhesion","volume":"120","author":"Symington","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.cden.2004.07.004_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0945-053X(94)90184-8","article-title":"A new nomenclature for the laminins","volume":"14","author":"Burgeson","year":"1994","journal-title":"Matrix Biol"},{"issue":"Suppl 1","key":"10.1016\/j.cden.2004.07.004_bib21","first-page":"9","article-title":"The desmosome and hemidesmosome in cutaneous autoimmunity","volume":"107","author":"Lin","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cden.2004.07.004_bib22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/10454411980090020201","article-title":"Molecular biological aspects of acquired bullous diseases","volume":"9","author":"Dabelsteen","year":"1998","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.cden.2004.07.004_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/1523-1747.ep12292701","article-title":"Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP 180 ectodomainin: evidence that BP180 spans the lamina lucida","volume":"108","author":"Bedane","year":"1997","journal-title":"J Inves Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The First International Consensus on Mucous Membrane Pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib25","first-page":"495","article-title":"Immunofluorescence studies in cicatricial pemphigoid","volume":"125","author":"Allen","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-2133.1999.02763.x","article-title":"Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity","volume":"140","author":"Setterfield","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0733-8635(18)30208-0","article-title":"Update on immunofluorescent testing in bullous diseases and lupus erythematosus","volume":"12","author":"Gately","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.cden.2004.07.004_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0190-9622(96)90604-0","article-title":"Reactivity of autoantibodies from patients with defined subepidermal bullous diseases against 1 mol\/L salt-split skin: specificity, sensitivity, and practical considerations","volume":"35","author":"Lazarova","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.md.0000076003.64510.00","article-title":"Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations","volume":"82","author":"Egan","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.cden.2004.07.004_bib30","first-page":"106","article-title":"Squamous cell carcinoma of the conjunctiva associated with benign mucous membrane pemphigoid","volume":"22","author":"Sivalingam","year":"1990","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.cden.2004.07.004_bib31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2133.1997.tb01118.x","article-title":"Anti-epiligrin (laminin-5) cicatricial pemphigoid and lung carcinoma: coincidence or association?","volume":"137","author":"Gibson","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2133.1999.02933.x","article-title":"Paraneoplastic cicatricial pemphigoid","volume":"141","author":"Setterfield","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s001050050697","article-title":"Cicatricial pemphigoid with autoantibodies to laminin-5 (epiligrin) in a patient with metastatic endometrial carcinoma","volume":"49","author":"Lenz","year":"1998","journal-title":"Huatarzt"},{"key":"10.1016\/j.cden.2004.07.004_bib34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1365-2133.1999.02773.x","article-title":"Antiepiligrin (laminin-5) cicatricial pemphigoid associated with an underlying gastric carcinoma producing laminin-5","volume":"140","author":"Taniuchi","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib35","first-page":"682","article-title":"Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita","volume":"139","author":"Fujimoto","year":"1998","journal-title":"Br J Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.cden.2004.07.004_bib36","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0190-9622(97)80237-X","article-title":"Anti-epiligrin cicatricial pemphigoid in a patient with HIV","volume":"36","author":"Lish","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib37","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/archderm.135.9.1091","article-title":"Antiepiligrin cicatricial pemphigoid: an underdiagnosed entity within the spectrum of scarring autoimmune subepidermal bullous diseases?","volume":"135","author":"Leverkus","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.284.3.350","article-title":"Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations","volume":"284","author":"Yancey","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cden.2004.07.004_bib39","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/0006-2952(93)90010-T","article-title":"Superoxide is an antagonist of anti-inflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase","volume":"45","author":"Kettle","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cden.2004.07.004_bib40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0006-2952(91)90323-W","article-title":"Mechanisms by which clofazimine and dapsone inhibit the myeloperoxidase system. A possible correlation with their anti-inflammatory properties","volume":"42","author":"Van Zyl","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cden.2004.07.004_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2133.1993.tb00476.x","article-title":"Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance","volume":"129","author":"Coleman","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jlb.62.6.827","article-title":"Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction","volume":"62","author":"Debol","year":"1997","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.cden.2004.07.004_bib43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/1523-1747.ep12614868","article-title":"Dermatitis herpetiformis","volume":"99","author":"Hall","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib44","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2141.1995.tb05179.x","article-title":"Dapsone for refractory chronic idiopathic thrombocytopenic purpura","volume":"90","author":"Hernandez","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cden.2004.07.004_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2340\/00015555755456","article-title":"Urticarial vasculitis syndrome effectively treated with dapsone and pentoxifylline","volume":"75","author":"Nurnberg","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cden.2004.07.004_bib46","first-page":"201","article-title":"Dapsone therapy of cicatricial pemphigoid","volume":"7","author":"Rogers","year":"1988","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib47","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2230.1994.tb01168.x","article-title":"Screening for glucose-6-phosphate dehydrogenase deficiency prior to dapsone therapy","volume":"19","author":"Todd","year":"1994","journal-title":"Clin Exp Dermaol"},{"key":"10.1016\/j.cden.2004.07.004_bib48","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2133.1995.tb05022.x","article-title":"Cimetidine improves the therapeutic\/toxic ratio of dapsone in patients on chronic dapsone therapy","volume":"132","author":"Rhodes","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib49","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/archderm.1984.01650480044015","article-title":"Vitamin E and dapsone-induced hemolysis","volume":"120","author":"Kelly","year":"1984","journal-title":"Arch Dermatol"},{"issue":"2 Pt 2","key":"10.1016\/j.cden.2004.07.004_bib50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0190-9622(96)90667-2","article-title":"Dapsone hypersensitivity syndrome","volume":"35","author":"Prussick","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib51","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.1995.tb00727.x","article-title":"Minimizing cicatricial pemphigoid orodynia with minocycline","volume":"132","author":"Poskitt","year":"1995","journal-title":"Br J Dermaol"},{"key":"10.1016\/j.cden.2004.07.004_bib52","first-page":"18","article-title":"Management of patients with severe oral mucosal disease","volume":"94","author":"Kim","year":"2001","journal-title":"Alpha Omegan"},{"key":"10.1016\/j.cden.2004.07.004_bib53","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archderm.1996.03890320082013","article-title":"Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature","volume":"132","author":"Knowles","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1365-2230.1998.00379.x","article-title":"Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: further support for its efficacy","volume":"23","author":"Reiche","year":"1998","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.cden.2004.07.004_bib55","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"}],"container-title":["Dental Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011853204000898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011853204000898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T23:22:58Z","timestamp":1706138578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011853204000898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0011853204000898"],"URL":"https:\/\/doi.org\/10.1016\/j.cden.2004.07.004","relation":{},"ISSN":["0011-8532"],"issn-type":[{"value":"0011-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}